Skip to main content

Advertisement

Log in

Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

We previously demonstrated that the detection of circulating cancer cells (CCC) expressing survivin mRNA could provide valuable information for predicting recurrence in patients with breast, lung, gastric and colorectal carcinoma. The purpose of this study is to investigate whether the detection of survivin-expressing CCC in the peripheral blood is also useful for predicting recurrence in patients with esophageal squamous cell carcinoma (ESCC). Blood samples obtained from 108 ESCC patients and 75 healthy volunteers were quantitatively investigated by a technique that detected reverse transcription-polymerase chain reaction products based on a hybridization-enzyme linked immunosorbent essay. Not all of the patients were available for the follow-up study. Only 48 patients who were treated with similar adjuvant therapy regimens were available and followed-up for 33 months after the initial assay test. Survivin-expressing CCC were detected in 51 (47.2%) patients. The presence of survivin-expressing CCC was found to be significantly associated with depth of invasion, vascular invasion, nodal status, and disease stages (P = 0.032, 0.019, 0.018, and 0.001, respectively). During the follow-up period, patients who had positive survivin expressions had a higher relapse rate and a shorter survival time than those who had negative survivin expressions (P = 0.002 and 0.016, respectively). Examination of survivin-expressing CCC could provide valuable information in the prediction of haematogenous recurrence as well as in the prognosis of ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Patel M, Ferry K, Franceschi D et al (2004) Esophageal carcinoma: current controversial topics. Cancer Invest 22:897–912. doi:10.1081/CNV-200039672

    Article  CAS  PubMed  Google Scholar 

  2. Roder JD, Stein HJ, Siewert JR (1995) Oesophageal carcinoma. In: Hermaneck P, Gospodarowicz MK, Henson DE (eds) Prognostic factors in cancer, UICC. Springer-Verlag, Berlin, p 37

    Google Scholar 

  3. Lee SJ, Lee KS, Yim YJ et al (2005) Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol 60:547–554. doi:10.1016/j.crad.2004.09.002

    Article  CAS  PubMed  Google Scholar 

  4. Huang P, Wang J, Guo Y et al (2003) Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 129:192–198

    CAS  PubMed  Google Scholar 

  5. Ikoma D, Ichikawa D, Ueda Y et al (2007) Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer. Anticancer Res 27:535–539

    PubMed  Google Scholar 

  6. Ito H, Kanda T, Nishimaki T et al (2004) Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction. J Exp Clin Cancer Res 23:455–464

    CAS  PubMed  Google Scholar 

  7. Kaganoi J, Shimada Y, Kano M et al (2004) Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. Br J Surg 91:1055–1060. doi:10.1002/bjs.4593

    Article  CAS  PubMed  Google Scholar 

  8. Koike M, Hibi K, Kasai Y et al (2002) Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood. Clin Cancer Res 8:2879–2882

    CAS  PubMed  Google Scholar 

  9. Liu Z, Jiang M, Zhao J et al (2007) Circulating tumor cells in preoperative esophageal cancer patients: quantitative assay system and potential clinical utility. Clin Cancer Res 13:2992–2997. doi:10.1158/1078-0432.CCR-06-2072

    Article  CAS  PubMed  Google Scholar 

  10. Nakashima S, Natsugoe S, Matsumoto M et al (2003) Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery 133:162–169. doi:10.1067/msy.2003.9

    Article  PubMed  Google Scholar 

  11. Chiou SK, Jones MK, Tarnawski AS (2003) Survivin–an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 9:125–129

    Google Scholar 

  12. Ambrosini G, Adida C, Altieri D (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921. doi:10.1038/nm0897-917

    Article  CAS  PubMed  Google Scholar 

  13. Grabowski P, Kühnel T, Mühr-Wilkenshoff F et al (2003) Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88:115–119. doi:10.1038/sj.bjc.6600696

    Article  CAS  PubMed  Google Scholar 

  14. Mega S, Miyamoto M, Li L et al (2006) Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma. Dis Esophagus 19:355–359. doi:10.1111/j.1442-2050.2006.00604.x

    Article  CAS  PubMed  Google Scholar 

  15. Rosato A, Pivetta M, Parenti A et al (2006) Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer 119:1717–1722. doi:10.1002/ijc.21923

    Article  CAS  PubMed  Google Scholar 

  16. Yie SM, Luo B, Ye NY et al (2006) Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Clin Exp Metastasis 23:279–289. doi:10.1007/s10585-006-9037-7

    Article  CAS  PubMed  Google Scholar 

  17. Yie SM, Lou B, Ye SR et al (2008) Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 15:3037–3082. doi:10.1245/s10434-008-0069-x

    Article  Google Scholar 

  18. Yie SM, Lou B, Ye SR et al (2009) Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer 63:284–290. doi:10.1016/j.lungcan.2008.05.024

    Article  PubMed  Google Scholar 

  19. Watanable H, Jass JR, Sobin LH (eds) (1990) Histological typing of esophageal and gastric tumors. Springer-Verlag, Berlin

    Google Scholar 

  20. Sobin H, Wittekind C (eds) (2002) UICC: TNM classification of malignant tumors, 6th edn. Wiley, New York

    Google Scholar 

  21. Yonenaga Y, Mori A, Onodera H et al (2005) Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients. Oncology 69:159–166

    Article  PubMed  Google Scholar 

  22. Mino-Miyagawa N, Kimura Y, Hamamoto K (1990) Tumor-antigen 4: its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus. Cancer 66:1505–1512. doi:10.1002/1097-0142(19901001)66:7<1505::AID-CNCR2820660712>3.0.CO;2-V

    Article  CAS  PubMed  Google Scholar 

  23. Katayama A, Mafune K, Tanaka Y et al (2003) Autopsy findings in patients after curative esophagectomy for esophageal carcinoma. J Am Coll Surg 196:866–873. doi:10.1016/S1072-7515(03)00116-9

    Article  PubMed  Google Scholar 

  24. Jiao X, Krasna MJ (2002) Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 74:278–284. doi:10.1016/S0003-4975(01)03376-8

    Article  PubMed  Google Scholar 

  25. Mehes G, Witt A, Kubista E et al (2001) Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159:17–20

    CAS  PubMed  Google Scholar 

  26. Brablets T, Jung A, Spaderna S et al (2005) Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5:744–749. doi:10.1038/nrc1694

    Article  Google Scholar 

  27. Zhang T, Otevrel T, Gao ZQ et al (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61:8664–8667

    CAS  PubMed  Google Scholar 

  28. Moriai R, Asanuma K, Kobayashi D et al (2001) Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res 21:595–600

    CAS  PubMed  Google Scholar 

  29. Torre GC (1998) SCC antigen in malignant and nonmalignant squamous lesions. Tumour Biol 19:517–526. doi:10.1159/000030045

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was partially supported by grants from the Chengdu Municipal Department of Science and Technology (Grant No. 07GGYB240SF-143), and the Sichuan Provincial Department of Science and Technology (Grant No. 07JY029-091).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shang-Mian Yie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cao, M., Yie, SM., Wu, SM. et al. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin Exp Metastasis 26, 751–758 (2009). https://doi.org/10.1007/s10585-009-9274-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-009-9274-7

Keywords

Navigation